Thrombolytic treated intravascular medical device

• US 5,380,299 A
• Filed: 08/30/1993
• Issued: 01/10/1995
• Est. Priority Date: 08/30/1993
• Status: Expired due to Term

• Current Assignee: Cook Medical Incorporated (Cook Group Incorporated)
• Original Assignee: MED Institute, Inc. (Cook Group Incorporated)
• Inventors: Fearnot, Neal E., Ragheb, Anthony O., Voorhees, William D. III
• Primary Examiner(s): Rosenbaum, C. Fred
• Assistant Examiner(s): SMITH, CHALIN A
• Application Number:
  US08/114,261
• Time in Patent Office: 498 Days
• Field of Search: 128/898, 604/890.1, 604/891.1, 604/892.1, 604/264, 604/265, 623/1, 623/11, 623/12
• US Class Current: 604/265
• CPC Class Codes: A61L 2300/254 Enzymes, proenzymes
• CPC Class Codes: A61L 2300/42 Anti-thrombotic agents, anticoagulants, anti-platelet agents
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: A61L 33/0011 Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
• CPC Class Codes: A61L 33/0047 Enzymes, e.g. urokinase, streptokinase

Abstract

An intravascular medical device having a structure shaped and sized for introduction into the vascular system of a patient including a base material and a coating of a thrombolytic agent on the base material. The thrombolytic agent advantageously dissolves or breaks up the formation of thrombus on the surface of the structure when placed in the vascular system of a patient. The intravascular medical device also includes a antithrombogenic agent for inhibiting the formation of thrombus on the surface of the medical device. The method of treating a medical device with a thrombolytic agent includes providing a base material for the medical device along with a thrombolytic agent. The base material is dipped into the thrombolytic agent and then removed to allow the thrombolytic agent to dry on the surface thereof. The dipping and drying steps are repeated to increase the concentration or quantity of the thrombolytic agent on the device.

Claims

1. An intravascular medical device comprising:

a structure shaped and sized for introduction into a vascular system of a patient, and structure including a base material and a homogeneous coating of a thrombolytic agent and at least one from a group consisting of a cellulose and a cellulose-based polymer on said base material.

2. The medical device of claim 1 wherein said base material comprises at least one from a group consisting of a metal, a carbon, a polymer, and a biologically derived material.

3. The medical device of claim 2 wherein said thrombolytic agent comprises at least one from a group consisting of urokinase, streptokinase, and a tissue plasminogen activator.

4. The medical device of claim 1 wherein said homogeneous coating further includes an antithrombogenic agent.

5. The medical device of claim 4 wherein said antithrombogenic agent comprises at least one from a group consisting of heparin, hirudin, and an antiplatelet.

6. The medical device of claim 5 wherein said cellulose-based polymer includes at least one from a group consisting of a cellulose acetate, a cellulose ester, and a cellulose nitrate.

7. The medical device of claim 2 wherein said metal includes at least one from a consisting of stainless steel, tantalum, nitinol, gold, platinum, inconel, and iridium.

8. An intravascular medical device comprising:

a structure shaped and sized for introduction into a vascular system of a patient, said structure including a base material and a homogeneous coating of at least one from a group consisting of a thrombolytic agent and an antithrombogenic agent and at least one from a group consisting of a cellulose and a cellulose-based polymer on said base material.

9. The medical device of claim 8 further including a primer agent for adhering an other of said thrombolytic agent and said antithrombogenic agent to said base material.

10. The medical device of claim 9 wherein said thrombolytic agent comprises at least one from a group consisting of urokinase, streptokinase, and a tissue plasminogen activator.

11. The medical device of claim 9 wherein said antithrombogenic agent comprises at least one from a group consisting of heparin, hirudin, and an antiplatelet.

12. The medical device of claim 9 wherein at least one of said primer agent and said cellulose-based polymer comprises at least one from a group consisting of a cellulose acetate, a cellulose ester and a cellulose nitrate.

13. An intravascular medical device comprising:

a structure shaped and sized for introduction into a vascular system of a patient, said structure including a thrombolytic agent and a base, homogeneous material including said thrombolytic agent and at least one from a group consisting of a cellulose, a cellulose acetate, a cellulose ester, and a cellulose nitrate.

14. The medical device of claim 13 wherein said structure includes an antithrombogenic agent.

15. The medical device of claim 14 wherein said structure includes a primer for adhering said antithrombogenic to said base material.

16. The medical device of claim 15 wherein said primer includes at least one of a group consisting of a cellulose, a cellulose acetate, a cellulose ester and a cellulose nitrate.

17. The medical device of claim 14 wherein said antithrombogenic agent comprises at least one from a group consisting of heparin, hirudin, and an antiplatelet.

18. The medical device of claim 13 wherein said thrombolytic agent comprises at least one from a group consisting of urokinase, streptokinase, and a tissue plasminogen activator.